Literature DB >> 14996689

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease.

P P Sfikakis, P H Kaklamanis, A Elezoglou, N Katsilambros, P G Theodossiadis, S Papaefthimiou, N Markomichelakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14996689     DOI： 10.7326/0003-4819-140-5-200403020-00025

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  47 in total

Review 1.  [Anti-TNF-α treatment for uveitis. Analysis of the current situation].

Authors:  U Pleyer; F Mackensen; S Winterhalter; N Stübiger
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

Review 2.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Biologic agents in the management of inflammatory eye diseases.

Authors:  Kira Michalova; Lyndell Lim
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

4.  Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis.

Authors:  Ilknur Tugal-Tutkun; Kürsat Cingü; Nur Kir; Baris Yeniad; Meri Urgancioglu; Ahmet Gül
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-27       Impact factor: 3.117

Review 5.  Clinical trials in noninfectious uveitis.

Authors:  Jane S Kim; Jared E Knickelbein; Robert B Nussenblatt; H Nida Sen
Journal:  Int Ophthalmol Clin       Date:  2015

6.  Psoriasis triggered by infliximab in a patient with Behçet's disease.

Authors:  Yuko Kawazoe; Sunao Sugita; Yukiko Yamada; Ai Akino; Keiko Miura; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2012-10-23       Impact factor: 2.447

7.  Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit.

Authors:  Panagiotis G Theodossiadis; Vasilios S Liarakos; Petros P Sfikakis; Alexander Charonis; Georgios Agrogiannis; Nikolaos Kavantzas; Ioannis A Vergados
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-04       Impact factor: 3.117

8.  Behçet's Uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

Review 9.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

10.  Managing Behçet's disease: An update on current and emerging treatment options.

Authors:  P La van Daele; J H Kappen; P M van Hagen; J Am van Laar
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.